These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32620863)

  • 1. Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing.
    Scharenberg SG; Poletto E; Lucot KL; Colella P; Sheikali A; Montine TJ; Porteus MH; Gomez-Ospina N
    Nat Commun; 2020 Jul; 11(1):3327. PubMed ID: 32620863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I.
    Gomez-Ospina N; Scharenberg SG; Mostrel N; Bak RO; Mantri S; Quadros RM; Gurumurthy CB; Lee C; Bao G; Suarez CJ; Khan S; Sawamoto K; Tomatsu S; Raj N; Attardi LD; Aurelian L; Porteus MH
    Nat Commun; 2019 Sep; 10(1):4045. PubMed ID: 31492863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector.
    Kim EY; Hong YB; Lai Z; Cho YH; Brady RO; Jung SC
    J Gene Med; 2005 Jul; 7(7):878-87. PubMed ID: 15712335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular diagnosis and gene therapy for Gaucher disease].
    Ohashi T
    Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells.
    Correll PH; Colilla S; Dave HP; Karlsson S
    Blood; 1992 Jul; 80(2):331-6. PubMed ID: 1627794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.
    Ohashi T; Boggs S; Robbins P; Bahnson A; Patrene K; Wei FS; Wei JF; Li J; Lucht L; Fei Y
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11332-6. PubMed ID: 1454816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and isolation of gene-corrected cells in Gaucher disease via a fluorescence-activated cell sorter assay for lysosomal glucocerebrosidase activity.
    Lorincz M; Herzenberg LA; Diwu Z; Barranger JA; Kerr WG
    Blood; 1997 May; 89(9):3412-20. PubMed ID: 9129049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
    Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
    Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
    Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gaucher Disease].
    Okuyama T
    Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
    Sgambato JA; Park TS; Miller D; Panicker LM; Sidransky E; Lun Y; Awad O; Bentzen SM; Zambidis ET; Feldman RA
    Stem Cells Transl Med; 2015 Aug; 4(8):878-86. PubMed ID: 26062980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Genome Editing System for Therapeutical Targeting of Stem Cells.
    Frati G; Miccio A
    Methods Mol Biol; 2021; 2185():383-398. PubMed ID: 33165862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
    Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
    Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Correction of the GBA Mutation in Human-Induced Pluripotent Stem Cells Restores Normal Function to Gaucher Macrophages and Increases Their Susceptibility to Mycobacterium tuberculosis.
    Ramalingam S; Kumar A; Krug S; Mohan H; Rao DN; Bishai WR; Chandrasegaran S
    J Infect Dis; 2023 Sep; 228(6):777-782. PubMed ID: 37159513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.